Table 3.
Baseline characteristics in the two treatment-arms
| LAT | AMIS | ||
|---|---|---|---|
| Age | |||
| N | 99 | 82 | p = 0.767 |
| Mean (sd) | 84.0 (6.6) | 84.4 (6.7) | |
| Median (10%, 90%) | 84.0 (75.0,92.0) | 86.0 (74.0,92.0) | |
| Gender | |||
| Male | 33/99 33.3% | 19/82 23.2% | p = 0.134 |
| Female | 66/99 66.7% | 63/82 76.8% | |
| Body Mass Index | |||
| N | 94 | 72 | p = 0.689 |
| Mean (sd) | 23.7 (4.9) | 23.8 (4.8) | |
| Median (10%, 90%) | 24.0 (18.0,29.0) | 23.0 (18.0,29.0) | |
| Residential status | |||
| Own home | 56/98 57.1% | 37/82 45.1% | p = 0.127 |
| Own home supported | 15/98 15.3% | 12/82 14.6% | |
| Assisted living | 4/98 4.1% | 9/82 11.0% | |
| Nursing home | 20/98 20.4% | 23/82 28.0% | |
| Other | 3/98 3.1% | 1/82 1.2% | |
| Walking aid | |||
| Yes | 45/98 45.9% | 51/81 63.0% | p = 0.023 |
| Dementia | |||
| Yes | 20/98 20.4% | 26/82 31.7% | p = 0.084 |
| MSQ | |||
| N | 92 | 77 | p = 0.312 |
| Mean (sd) | 7.9 (2.9) | 7.5 (3.1) | |
| Median (10%, 90%) | 9.0 (3.0,10.0) | 9.0 (2.0,10.0) | |
| pfFIM | |||
| N | 93 | 75 | p = 0.860 |
| Mean (sd) | 107.0 (26.6) | 107.8 (24.5) | |
| Median (10%, 90%) | 123.0 (63.0,126.0) | 120.0 (67.0,126.0) | |
| Number of medications | |||
| N | 97 | 82 | p = 0.524 |
| Mean (sd) | 6.9 (4.4) | 6.5 (4.4) | |
| Median (10%, 90%) | 6.0 (2.0,13.0) | 6.0 (1.0,12.0) | |
| Charlson Comorbidity Score | |||
| N | 98 | 79 | p = 0.952 |
| Mean (sd) | 2.3 (2.1) | 2.3 (2.2) | |
| Median (10%, 90%) | 2.0 (0.0,5.0) | 2.0 (0.0,5.0) | |
| Frailty Index | |||
| N | 92 | 73 | p = 0.739 |
| Mean (sd) | 0.18 (0.15) | 0.17 (0.16) | |
| Median (10%, 90%) | 0.12 (0.01,0.40) | 0.13 (0.03,0.41) | |
| ASA score | |||
| 2 | 33/99 33.3% | 23/82 28.0% | p = 0.436 |
| 3 | 62/99 62.6% | 55/82 67.1% | |
| 4 | 4/99 4.0% | 4/82 4.9% | |
| Time until surgery (hours) | |||
| N | 97 | 82 | p = 0.943 |
| Mean (sd) | 27.4 (18.9) | 25.6 (14.4) | |
| Median (10%, 90%) | 23.0 (7.0,52.0) | 24.0 (7.0,44.0) | |
| Haemoglobin | |||
| N | 98 | 82 | p = 0.901 |
| Mean (sd) | 129.5 (16.1) | 129.9 (15.7) | |
| Median (10%, 90%) | 132.5 (109.0,149.0) | 130.0 (107.0,149.0) | |
| Creatinine | |||
| N | 95 | 76 | p = 0.596 |
| Mean (sd) | 19.8 (10.1) | 19.5 (11.9) | |
| Median (10%, 90%) | 17.0 (10.0,30.0) | 17.0 (10.0,29.0) | |
| Albumin | |||
| N | 98 | 82 | p = 0.674 |
| Mean (sd) | 33.7 (6.9) | 34.0 (4.7) | |
| Median (10%, 90%) | 35.0 (28.0,40.0) | 34.0 (29.0,39.0) | |
| CRP | |||
| N | 98 | 82 | p = 0.512 |
| Mean (sd) | 15.7 (29.7) | 17.9 (27.1) | |
| Median (10%, 90%) | 4.0 (1.0,58.0) | 6.0 (0.0,49.0) | |
| Leukocytes | |||
| N | 98 | 82 | p = 0.997 |
| Mean (sd) | 10.3 (3.7) | 10.2 (3.6) | |
| Median (10%, 90%) | 10.0 (6.0,15.0) | 10.0 (6.0,15.0) | |
Basic patient characteristics, although the groups are comparable there is a higher degree of frailty associated factors apparent in the AMIS- arm with a higher level of support (65% vs 43%), a more frequent use of walking aids (63% vs 46%) and a higher rate of diagnosed dementia (32% vs 20%)